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Abstract 
The main aim of our research was development of a novel selective electrochemical method for imipramine (IMI) detection. This 
substance enable to interact with DNA and it is also electrochemically active. Two major groups of electrochemical sensors were 
used in the experiments with bare gold electrodes and DNA-modified. Determination of imipramine by means of non-modified 
electrodes was not selective and limit of detection was shifted towards higher concentrations of IMI. The sensitivity of mixed and 
mono-GC sequence DNA-modified electrodes was much higher than for the bare gold ones. 
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1. Introduction 
The DNA biosensors provide fast, simple, sensitive and selective detection of target substance through its 
interaction with double-stranded DNA immobilized on the active sensors surface. Imipramine (IMI) is a tricyclic 
antidepressant (TCA), which belongs to the dibenzazepine group. Due to side-effects for depressive patients treated 
using these drugs, which may be toxicity and/or inability to drive mechanical vehicles [1], their determination is 
important in clinical diagnostics. There are a few reports related to electrochemical IMI detection including 
utilization of highly boron-doped diamond electrodes [1], functionalized carbon paste electrodes [2] and indium-tin 
oxide (ITO) electrodes modified with molecularly imprinted polymer (MIP) and Au-nanoparticles [3]. 
 
Nomenclature 
AA ascorbic acid 
CPZ chlorpromazine 
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DPV differential pulse voltammetry 
IMI imipramine 
LOD limit of detection 
LSV linear sweep voltammetry 
PCT acetaminophen (in latine: paracetamolum) 
SD standard deviation 
2. Experimental 
2.1. Chemicals 
The 21-mer modified (at 3’-end) oligonucleotide HS-(CH2)3-3’-AAG GCC GAC TCA GTA GTT CGC-5’ and 
complementary strand 5’-TTC CGG CTG AGT CAT CAA GCG-3’ were synthesized by Oligo.pl (Warsaw, 
Poland). The 21-mer modified (at 3’-end) oligonucleotides HS-(CH2)3-3’-(A)21-5’ and HS-(CH2)3-3’-(G)21-5’ and 
respectively complementary strands 5’-(T)21-3’, 5’-(C)21-3’ were synthesized by Genomed. Acetaminophen,  
L-ascorbic acid, imipramine and 6-mercapto-1-hexanol were obtained from Sigma-Aldrich. Chlorpromazine was 
obtained from MP Biomedicals, LLC. Analytical grade reagents and purified water from Millipore Milli-Q system 
were used for the preparation of phosphate buffer solution.  
2.2. Sensors fabrication and measurements  
In experiments, gold paste electrochemical sensors manufactured by microdosing robot, fabricated in our 
laboratory [4], were modified with the use of short thiol-labeled oligonucleotides HS-(CH2)3-3’-AAG GCC GAC 
TCA GTA GTT CGC-5’ and complementary strands 5’-TTC CGG CTG AGT CAT CAA GCG-3’ forming mixed 
sequence DNA. After immobilization of thiol–labeled strands, extant free surface was blocked by means of  
6-mercapto-1-hexanol. Then hybridization with complementary strand was performed at room temperature for 1 h. 
For elimination of non-specific binding of DNA strands, after each step the electrodes were vigorously rinsed with 
MQ water. The biosensors prepared according to the described procedure were incubated in solutions of imipramine 
at concentration range from 0.0005 to 50.0 μM for 2 min, afterwards electrodes were rinsed.  
In the next stage of experiments sensors were modified (according to above-described procedure) with use one of 
the short thiol-labeled oligonucleotides HS-(CH2)3-3’-(A)21-5’ or HS-(CH2)3-3’-(G)21-5’ then hybridized with 
complementary strands 5’-(T)21-3’ and 5’-(C)21-3’, to form mono-AT, and mono-GC sequence DNA, respectively. 
Prepared biosensors were incubated in solutions of imipramine at concentration range from 0.005 to 0.1 μM for  
2 min, next electrodes were rinsed.  
Afterwards electrochemical measurements were performed in 0.17 M phosphate buffer solution (pH 7.5), by 
differential pulse voltammetry (DPV) with the use of PalmSens potentiostat (Palm Instruments BV, The 
Netherlands). For comparison the same procedure was applied for measurements of imipramine with use of bare 
gold electrodes and DNA modified ones. 
The last stage of experiments were measurements in sample containing 400 nM IMI, 50 μM CPZ, 200 μM PCT 
and 2000 μM AA with the use of two measuring methods DPV and linear sweep voltammetry (LSV). 
3. Results 
Comparison of the performances of the electrochemical sensors for imipramine with bare gold electrodes and 
DNA modified ones are shown in Fig. 1a and Fig. 1b. Linear concentration range of imipramine determination by 
means of DNA-modified electrodes is significantly shifted towards lower concentrations. In this case of DNA-
modified biosensors low detection limit is c.a. 0.0005 μM, while for sensors with bare gold electrodes – c.a. 1 μM. 
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Fig. 1. (a) Exemplary differential pulse voltammograms with corrected baseline obtained with bare gold electrodes incubated in imipramine 
solutions of concentration from 1 to 30 μM. Measurements performed in 0.17 M phosphate buffer (pH 7.5), (b) Exemplary differential pulse 
voltammograms with corrected baseline obtained on DNA-modified gold electrodes incubated in imipramine solutions of concentration from 
0.0005 to 0.1 μM. Measurements performed in 0.17 M phosphate buffer (pH 7.5). DPV method with the following parameters Estep: 7 mV, 
Epulse:0.80 mV, scan rate: 30 mV/s. 
As it can be seen in Fig. 2. the best results (the highest oxidation peaks) and lower standard deviation values were 
obtained for Au electrodes modified with mixed sequence DNA, while Au modification with mono-GC sequence 
DNA effects in lower imipramine oxidation peaks and higher standard deviation values. For Au modification with 
mono-AT sequence DNA imipramine oxidation peaks do not occur.  
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Fig. 2. Calibration curves corresponding with imipramine oxidation peaks height (n=4, ±SD) obtained for electrodes modified with mixed 
sequence DNA (blue series), mono-GC DNA (red series) and mono-AT DNA (green series). DPV method with the following parameters  
Estep: 7 mV, Epulse: 0.80 mV, scan rate: 30 mV/s. 
In the case of non-modified electrodes, determination of imipramine was not selective and shifted towards high 
concentration range (Fig. 3). The resulting sensitivity of DNA-modified electrodes was much higher than for the 
bare gold electrodes. For the above mentioned three group of sensors – 1) bare gold electrodes measured in 
imipramine solutions, 2) bare gold electrodes measured in phosphate buffer solution after 2-minute incubation and  
3)  mixed sequence DNA-modified electrodes, imipramine linear concentration ranges are as follows: 10.0 – 50.0 
μM, 2.0 – 30.0μM, 0.005 – 0.05 μM, respectively. 
As it can be seen in Fig. 4, in the case of DPV method both peaks corresponding with peak potentials 
chlorpromazine (c.a. +0.55V) and imipramine (c.a. +0.74 V) are visible. Using LSV method only one, 
chlorpromazine oxidation peak (c.a. +0.66 V) is visible, what corresponds with results obtained previously described 
in paper [5]. 
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Fig. 3. Calibration curves for imipramine based on differential pulse voltammograms with corrected baseline obtained in IMI solutions on bare 
gold electrodes (red series), in phosphate buffer of pH 7.5 after 2 min incubation in IMI solutions on bare gold electrodes (series green) and on 
DNA-modified gold electrodes in phosphate buffer of pH 7.5 (blue series), (n=4, ±SD). 
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Fig. 4. (a) Exemplary DPV with corrected baseline obtained for bare gold electrode – red line, for DNA-modified gold electrode (mixed 
sequence) – blue line, for DNA - modified gold electrode mono-GC – green line. DPV method: Estep: 7 mV, Epulse: 0.80 mV, scan rate: 30 mV/s. 
(b) Exemplary LSV with corrected baseline obtained for bare gold electrode – red line, for DNA-modified gold electrode (mixed sequence) – 
blue line, for DNA - modified gold electrode mono-GC – green line. All measurements performed in 0.17 M phosphate buffer (pH 7.5) after 
2-min incubation in samples containing mixture of IMI – 400 nM, CPZ – 50 μM, PCT – 200 μM, AA – 2000 μM. LSV method Estep: 5 mV, scan 
rate: 100 mV/s. 
Summarizing, determination of imipramine by means of non-modified electrodes was not selective and limit of 
detection was shifted towards higher concentrations of imipramine. The sensitivity of mixed and mono-GC 
sequence DNA-modified electrodes was much higher than for the bare gold ones. 
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